Dr. Timothy Fuller, MD

Dr. Fuller practices at Texas Retina Associates in Dallas, Texas.

Dr. Fuller's NPI, 1811261316, was assigned on March 1, 2012. Dr. Fuller graduated from McGovern Medical School at UTHealth in 2010. Dr. Fuller holds Texas license Q0438.

Dr. Fuller's primary practice is Texas Retina Associates, at 9600 N Central Expy, Dallas, TX 75231 in Dallas County. The practice phone is (214) 692-6941.

Dr. Fuller's primary practice is Texas Retina Associates in Dallas, Texas. Dr. Fuller is also affiliated with Texas Health Dallas. Dmand AI also links Dr. Fuller to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fuller practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Fuller's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Fuller is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Fuller's licenses on file in 2 states: Texas and Pennsylvania.

Dmand AI lists age-related macular degeneration, cataract, dry eye, eyelid inflammation, hypertensive retinopathy, inflammation of iris, laser destruction of retinal or choroid lesions and retinal detachment among the conditions Dr. Fuller treats.

CMS data shows 96,402 Medicare services from Dr. Fuller across 21 procedure codes in 2024, for 1,500 Medicare patients. Medicare paid $4,130,705 for them. Every service was in an office.

CMS counts 1,500 Medicare patients who saw Dr. Fuller in 2024. The largest group is 65 to 74, with 573 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 4% are also on Medicaid. Their average risk score is 1.34, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Fuller's median patient age at 74, with 59% women.

In 2024, Dr. Fuller wrote 264 Medicare Part D claims for 101 patients. 73% of them were for generic drugs. CMS names the drug for 186 of them, across 8 drugs with 11 or more claims each, at $10,568 in total drug cost. In 2023, CMS named 163 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Fuller for performance year 2024, reported as part of a group. Dr. Fuller accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Dr. Fuller in 2020. The most frequent topics are Tomography, Optical Coherence.

CMS Open Payments shows 24 general payments to Dr. Fuller from 11 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Apellis Pharmaceuticals, Inc. paid the most, $404.

Dr. Fuller graduated from McGovern Medical School at UTHealth in 2010.

Dr. Fuller is in network with 21 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 13. Check the plan with the practice before a visit.